Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.
from NDTV News - Latest https://ift.tt/3x0xVOe
Thursday, November 18, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment